Last edition
News about Manufacturing
Piramal Pharma, NewAmsterdam Launch Dedicated OSD Suite at Sellersville Site in US
Piramal Pharma Solutions and NewAmsterdam Pharma have inaugurated a dedicated oral solid dosage (OSD) suite at Piramal’s Sellersville, Pennsylvania facility to support the production of NewAmsterdam’s investigational fixed-dose combination cholesterol therapy.
Manufacturing | 21/08/2025 | By Mrinmoy Dey | 291
Welcure Drugs to Invest INR 70 Crore in New Agro-Pharma Research Lab
Welcure Drugs and Pharmaceuticals has announced its plan to establish an agro-pharma research laboratory with an investment of INR 70-80 crore.
Manufacturing | 21/08/2025 | By Dineshwori | 395
PLI Scheme Transforms India from Net Importer to Net Exporter of Bulk Drugs in Just Three Years
The PLI scheme has helped India shift from being a net importer of bulk drugs (– INR 1,930 crore in FY 2021-22) to a net exporter (INR 2,280 crore), while significantly reducing the gap between domestic manufacturing capacity and the demand for critical drugs.
Manufacturing | 20/08/2025 | By Dineshwori | 601
Orbia's New Whitepaper Charts Regulatory Path to Low-GWP Propellant Manufacturing for pMDIs
Orbia Fluor and Energy Materials has published a new whitepaper, produced in collaboration with DLRC Group, that offers vital regulatory guidance to support the pharmaceutical industry's transition to low-global warming potential (low-GWP) propellants in pressurised metered dose inhalers (pMDIs).
Manufacturing | 19/08/2025 | By Darshana | 139
WuXi Biologics, a leading global contract research, development and manufacturing organisation (CRDMO), has announced that its Dundalk, Ireland facility has been approved by the European Medicines Agency (EMA) as a commercial manufacturing site for a client’s innovative biologic.
Manufacturing | 18/08/2025 | By Dineshwori | 286
Zydus Lifesciences' Ahmedabad Manufacturing Plant Clears US FDA Inspection with Zero Observations
The inspection, which took place from 11 to 13 August 2025, evaluated three products under general current Good Manufacturing Practice (cGMP) standards and concluded without any regulatory findings or compliance issues.
Manufacturing | 18/08/2025 | By Darshana | 554
AbbVie to Invest USD 195 Million to Expand API Manufacturing in US
AbbVie will invest USD 195 million to expand active pharmaceutical ingredient manufacturing at its North Chicago plant, strengthening US production capacity for current and next-generation medicines.
Manufacturing | 13/08/2025 | By Mrinmoy Dey | 154
Cohance Lifesciences to Invest USD 10 Million to Expand cGMP Bioconjugation Capabilities in US
Cohance Lifesciences will invest USD 10 million to expand cGMP bioconjugation capabilities at its US-based subsidiary NJ Bio, strengthening its integrated Antibody-Drug Conjugate manufacturing capacity for global innovators.
Manufacturing | 13/08/2025 | By Mrinmoy Dey | 356
ProBio Opens GMP AAV Manufacturing Facility in Hopewell, US to Support Gene Therapy Development
ProBio has launched its cGMP Adeno-Associated Virus (AAV) manufacturing services at its state-of-the-art Hopewell, New Jersey facility, offering fully integrated, end-to-end viral vector production to support the advancement of gene therapies.
Manufacturing | 12/08/2025 | By Mrinmoy Dey | 216
WuXi Biologics Unveils WuXia293Stable Platform to Advance Manufacturing of Complex Biologics
Featuring high titers, robust stability and superior quality, the platform enhances both the developability and manufacturability of complex biologics, providing an efficient chemistry, manufacturing and controls (CMC) solution for sophisticated structures and functions.
Manufacturing | 12/08/2025 | By Darshana | 393
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy